Form 4 Filing for Kiniksa Pharmaceuticals International, plc

This filing details transactions by John F. Paolini, Chief Medical Officer of Kiniksa Pharmaceuticals International, plc. On April 7, 2026, Paolini acquired 2,497 Class A Ordinary Shares through the vesting of Restricted Share Units (RSUs) with a transaction price of $0.00. Following this, he disposed of 1,208 Class A Ordinary Shares at a price of $48.94 per share. The RSUs vest over a four-year period, with 25% vesting annually from the grant date of April 7, 2022. Post-transaction, Paolini holds 65,623 Class A Ordinary Shares directly.